期刊文献+

同型半胱氨酸与骨质疏松症的关系 被引量:8

The relationship between homocysteine and osteoporosis
下载PDF
导出
摘要 近年流行病学研究表明,血中同型半胱氨酸水平与骨质疏松和骨质疏松性骨折具有积极相关性,高同型半胱氨酸血症是骨质疏松及骨质疏松性骨折发生重要的危险因素。在机理上,同型半胱氨酸主要通过影响骨胶原的交联,增强破骨细胞的活性、形成,及促进成骨细胞的凋亡起作用的。笔者将从同型半胱氨酸的代谢,及其与骨量、骨质量和骨的代谢等方面的关系进行综述。进一步阐明如何预防和治疗由高同型半胱氨酸血症所导致的骨质疏松症。 From recent cpidemiological studies, a positive association has been found between plasma homocysteine levels and osteoporosis as well as osteoporotic fracture. Hyperhomocysteinemia is an important risk factor for developing osteoporosis and osteoporotic fracture. The main mechanisms include that, homocystein affects collagen crosslinking formation in bone, enhances activity and formation of osteoclast, promotes apoptosis of osteoblast. This article will summarize the metabolism of homocysteine, and its relationship with bone mass, bone quality and metabolism of bone. And further illustrate, how to prevent and treat osteoporosis caused by homocysteinemia.
作者 赖欧杰 沈彬
出处 《中国骨质疏松杂志》 CAS CSCD 2009年第8期625-628,575,共5页 Chinese Journal of Osteoporosis
关键词 同型半胱氨酸 骨量 骨质量 骨质疏松 骨质疏松性骨折 Homocysteine Bone mass Bone quality Osteoporosis Osteoporotic fracture
  • 相关文献

参考文献27

  • 1Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteopomsis: 2001 edition, with selected updates for 2003. Endocr Pract, 2003, 9(6) : 544-564.
  • 2van Meurs JB, Dhonukshe-Rutten RA. Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med, 2004, 350(20): 2033-2041.
  • 3McLean P,.R, Jacques PF, Selhub J, et al. Homocystelne as a predictive factor for hip fracture in older persons. N Engl J Med, 2004, 350(20): 2042-2049.
  • 4Sato Y, Iwamoto J, Kanoko T, et al. Homoeyselne as a predictive factor for hip fracture in elderly women with Parkinson's disease. Am J Med, 2005, 118: 1250-1255.
  • 5Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 1995, 10(1): 111-113.
  • 6Miyao hi, Morita H, Hosoi T, et al. Association of methylenetetrahydrofolate reductase ( MTHFR ) polymorphism with bone mineral density Jn postmenopausal Japanese women. Caleif Tissue Int, 2000, 66(3) : 190-194.
  • 7Yazdanpanah N, Uitterlinden AG, Zillikens MC, et al. Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele. J Bone Miner Res, 2008, 23 (1) : 86-94.
  • 8SirJs ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low lone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA, 2001, 286(22): 2815-2822.
  • 9Wang X, Shen X, Li X, et al. Age-related changes in the collagen network and toughness of bone, Bone, 2002, 31(1) : 1-7.
  • 10Cauley JA, Hochberg MC, Liu LY, et al. Long-term risk of incident vertebral fractures. JAMA, 2007, 298(23): 2761-2767.

同被引文献200

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部